GlucoTab ‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes
ConclusionsTreatment with GlucoTab using insulin glargine U300 in hospitalized patients with T2D is effective and safe.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Felix Aberer,
Katharina M. Lichtenegger,
Edin Smajic,
Klaus Donsa,
Oliver Malle,
Judith Samonigg,
Bernhard H öll,
Peter Beck,
Thomas R. Pieber,
Johannes Plank,
Julia K. Mader Tags: ORIGINAL ARTICLE Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Lantus | Obesity | Study